Impact of delisting melatonin from a health-system formulary on psychotropic utilization
Published online on April 29, 2026
Abstract
Australasian Psychiatry, Ahead of Print.
ObjectiveTo characterize the trends of psychotropic utilization before and after the formulary removal of melatonin in Alberta, Canada.MethodsWe conducted a retrospective drug utilization review of patients admitted to inpatient, long-term care, and ...
ObjectiveTo characterize the trends of psychotropic utilization before and after the formulary removal of melatonin in Alberta, Canada.MethodsWe conducted a retrospective drug utilization review of patients admitted to inpatient, long-term care, and ...